Skip to content
WeighLab
Menu

Evidence review

What Compounded GLP-1 Actually Costs Per Month

A cost guide to compounded semaglutide and tirzepatide: real disclosed ranges of roughly $65–$349/mo, what drives the spread, and how to model your own number.

By The WeighLab Bench, Tools & Data Desk

Ask five telehealth sites what compounded GLP-1 costs and you will get five different answers, several of them intro rates that will not last. This is a plain cost guide: the real disclosed ranges across the providers we track, what moves the number up or down, and how to model what you will personally pay for a year.

The headline range: about $65 to $349 per month

Across the compounded GLP-1 providers on the Cost-Efficiency Index, disclosed monthly prices run from roughly $65 at the low end to about $349 at the high end (per each provider's published pricing, last reviewed 2026). The cheapest sticker on the board is Primary Clinic / Direct GLP at $65 for semaglutide — but it serves only about 10 states, which is exactly why sticker price alone is misleading. In the value tier, verified all-50-state providers such as Vitara RX at $99 semaglutide and Ondra Health at $93 show what a low price plus nationwide access actually looks like.

What drives the spread

Four things move your monthly cost:

Molecule. Semaglutide is usually cheaper than tirzepatide; some providers list both at the same price, others charge a clear premium for tirzepatide. We compare them in semaglutide vs tirzepatide.

Dose. Compounded pricing is often flat per month regardless of dose at a given provider, but not always — some tiers rise as your dose escalates, which matters because most people titrate upward over their first few months.

Provider positioning. Budget operators compete on raw price; premium ones charge more for stronger disclosure, oversight, or brand access. A mid-market $149–$199 flat price from an all-50, verified provider is often the best true value even though it is not the lowest sticker.

Bundling. Some prices include clinician visits and shipping; others add fees. Always confirm what the number includes.

Sticker price is not annual cost

The number on the landing page is a starting point, not a total. Two things routinely make your real cost higher: teaser rates that step up after the first month, and dose escalation that can shift you into a higher price tier. A $99 intro that becomes $199 in month two costs about $2,090 over a year, not $1,188 — a difference that changes which provider is actually cheapest. We walk through the full method in the true monthly cost of GLP-1.

Model your own number

Do not trust a single sticker — build the year. Use the cost calculators to plug in a provider's disclosed price, add any month-two step-up, and multiply out 12 months. Then compare finalists on total annual cost side by side with the compare tool. One note on what you are buying: compounded GLP-1 medication is not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs1 — so weigh price against a verifiable pharmacy, not in isolation. The compounded market exists at this price largely because these molecules spent time on the FDA drug-shortage list, which permits compounding under defined conditions2; we cover what that means for you in is compounded semaglutide legit and safe.

Frequently asked questions

How much does compounded semaglutide cost per month?

Across the providers we track, disclosed compounded semaglutide runs from roughly $65 to about $249 per month, with several verified all-50-state options in the $93–$149 range (per each provider's published pricing, last reviewed 2026).

Why is the cheapest provider not always the best value?

The lowest sticker often comes from providers serving only a few states or from intro rates that step up after month one. Value is price plus access, verification, and a modelable full-year total.

Does the monthly price go up as my dose increases?

At many providers the price is flat per month regardless of dose, but some tier pricing by dose. Since most people titrate upward early on, confirm whether escalation moves you into a higher tier.

References

  1. U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  2. U.S. Food and Drug Administration (2024). FDA Drug Shortages Database. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/drugshortages/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.